Literature DB >> 2839580

A serological investigation of BK virus and JC virus infections in recipients of renal allografts.

C A Andrews1, K V Shah, R W Daniel, M S Hirsch, R H Rubin.   

Abstract

BK virus (BKV) and JC virus (JCV) infections were evaluated in a serological study of 496 renal transplant recipients and their donors. A seropositive donor increased the rate of primary and reactivation infections with BKV and of primary infections with JCV. BKV infection rates were not influenced by the source of the renal allograft (cadaver versus living related donor); however, primary JCV infections occurred more often in recipients of seropositive cadaveric kidneys. Reactivated JCV infections occurred less frequently in patients treated with antilymphocyte preparation. BKV and JCV infections in renal transplant recipients may be caused either by reactivation of the recipient's latent virus or by virus from the donor kidney. These infections are, however, not associated with adverse outcome (death, high serum creatinine level, or loss of renal function) in the recipient in the early post-transplant period.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839580     DOI: 10.1093/infdis/158.1.176

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

1.  BKV-DNA and JCV-DNA co-quantification assay to evaluate viral load in urine and serum.

Authors:  Chiara Merlino; Massimiliano Bergallo; Roberta Daniele; Alessandro Negro Ponzi; Rossana Cavallo
Journal:  Mol Biotechnol       Date:  2005-05       Impact factor: 2.695

2.  Identification of gangliosides GD1b and GT1b as receptors for BK virus.

Authors:  Jonathan A Low; Brian Magnuson; Billy Tsai; Michael J Imperiale
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

Review 3.  BK polyomavirus infection and nephropathy: the virus-immune system interplay.

Authors:  Nina Babel; Hans-Dieter Volk; Petra Reinke
Journal:  Nat Rev Nephrol       Date:  2011-05-24       Impact factor: 28.314

4.  Urinary Tract Infections in Renal Transplant Recipients.

Authors:  Patricia D. Brown
Journal:  Curr Infect Dis Rep       Date:  2002-12       Impact factor: 3.725

5.  Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial.

Authors:  Belinda T Lee; Steven Gabardi; Monica Grafals; R Michael Hofmann; Enver Akalin; Aws Aljanabi; Didier A Mandelbrot; Deborah B Adey; Eliot Heher; Pang-Yen Fan; Sarah Conte; Christine Dyer-Ward; Anil Chandraker
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-30       Impact factor: 8.237

6.  Cynomolgus polyoma virus infection: a new member of the polyoma virus family causes interstitial nephritis, ureteritis, and enteritis in immunosuppressed cynomolgus monkeys.

Authors:  M A van Gorder; P Della Pelle; J W Henson; D H Sachs; A B Cosimi; R B Colvin
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

7.  Validation of BKV large T-antigen ATP-binding site as a target for drug discovery.

Authors:  Gang Zeng; Marta Bueno; Carlos J Camachos; Bala Ramaswami; Chunqing Luo; Parmjeet Randhawa
Journal:  Antiviral Res       Date:  2008-12-11       Impact factor: 5.970

8.  Monitoring of polyomavirus BK virus viruria and viremia in renal allograft recipients by use of a quantitative real-time PCR assay: one-year prospective study.

Authors:  Xiaoli L Pang; Karen Doucette; Barbara LeBlanc; Sandra M Cockfield; Jutta K Preiksaitis
Journal:  J Clin Microbiol       Date:  2007-09-12       Impact factor: 5.948

9.  Detection and typing of BKV, JCV, and SV40 by multiplex nested polymerase chain reaction.

Authors:  Massimiliano Bergallo; Cristina Costa; Samuela Margio; Francesca Sidoti; Giuseppe P Segoloni; Alessandro Negro Ponzi; Rossana Cavallo
Journal:  Mol Biotechnol       Date:  2007-03       Impact factor: 2.695

10.  Antibody responses to recombinant polyomavirus BK large T and VP1 proteins in young kidney transplant patients.

Authors:  Sohrab Bodaghi; Patrizia Comoli; Robert Bösch; Alberta Azzi; Rainer Gosert; David Leuenberger; Fabrizio Ginevri; Hans H Hirsch
Journal:  J Clin Microbiol       Date:  2009-05-27       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.